Brief: Ribomic announces R& D on therapeutic aptamer against FGF2 jointly with three universities
27/09/2016 07:31
Sept 27 (Reuters) - Ribomic Inc 4591.T :
* Says it signed contract with Keio University's faculties
of medicine, Osaka University's faculties of medicine and
Juntendo University's faculties of medicine on R& D of
therapeutic aptamer against fibroblast growth factor 2(FGF2)
Source text in Japanese:https://goo.gl/wQwisg
Further company coverage: 4591.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))